HVD Policy Task Force Comments on MCIT Repeal
Dear Administrator Brooks-LaSure: Heart Valve Voice US is submitting these comments on behalf of the Heart Valve Disease PolicyTask Force,...
Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490)
The Heart Valve Disease Policy Task Force represents a diverse group of patient,disease, and research advocacy groups with a shared...
HVV US is advocating for patients with mitral valve disease. See our comments to CMS
Telehealth offers significant advantages to patients of all types, including and especially older Americans with mobility and other age-associated health...
CMS Releases CY 2021 IPPS Proposed Rule
On May 12, the Centers for Medicare and Medicaid Services (CMS) released its Calendar Year (CY) Inpatient Prospective Payment System...
Heart Valve Voice US Responds to COVID-19 Pandemic
Heart Valve Voice US has been tracking the impact of COVID-19 on our patient community and has published several guidance...
CMS National Coverage Determination for TMVR Forthcoming
On Feb. 18, 2020, the Centers for Medicare and Medicaid Services (CMS) announced that a decision on a National Coverage...
CMS Decision on TAVR Puts Patients at the End of the Line
The Centers for Medicaid and Medicare Services today issued their final National Coverage Decision on how hospitals will be approved...
CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients
Washington, D.C., March 27, 2019 – Below is a statement issued on behalf of the Alliance for Aging Research, Association of Black...